Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Net income from continuing operations | 580.42%5.72M | 10.81%840.17K | 146.47%758.21K | -168.94%-1.63M | 236.22%2.37M | -216.13%-1.74M | 157.16%1.5M | -177.23%-2.62M | 89.52%3.39M | 2,757.76%1.79M |
| Change in working capital | -574.11%-3.32M | 1.58%-492.17K | -143.82%-500.09K | 310.46%1.14M | -317.33%-542.28K | 119.33%249.52K | -143.28%-1.29M | 119.70%2.98M | 143.89%1.36M | -212.91%-3.09M |
| -Change in receivables | 75.44%-15.29K | -2,104.22%-62.25K | 14.19%3.11K | 154.11%2.72K | -85.64%-5.03K | -114.84%-2.71K | -82.53%18.24K | 220.88%104.45K | -2,169.74%-86.41K | -115.87%-3.81K |
| -Change in prepaid assets | ---89.44K | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in other current assets | -695.81%-3.26M | 18.00%-409.65K | -143.79%-499.57K | 302.31%1.14M | -318.22%-563.95K | 119.71%258.43K | -145.35%-1.31M | 100.55%2.89M | 146.86%1.44M | -212.19%-3.08M |
| -Change in other current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued operating activities | ||||||||||
| Operating cash flow | -409.76%-37.78M | -678.85%-7.41M | 107.12%1.28M | -63.56%618.24K | 45.38%1.7M | 167.93%1.17M | -110.96%-1.72M | 925.46%15.67M | -29.67%1.53M | -49.93%2.17M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Net commonstock issuance | 353.71%43.7M | 22,184.83%9.63M | -137.80%-43.61K | 92.45%-18.34K | -463.65%-243.06K | 79.21%-43.12K | 93.71%-207.38K | -1,759.23%-3.29M | -12.71%-177.21K | 78.69%-157.23K |
| Net preferred stock issuance | --0 | -310.53%-2.04M | -219.89%-496.85K | 81.54%-155.32K | 20.03%-841.53K | -48.77%-1.05M | 91.90%-707.29K | -1,861.14%-8.73M | 45.58%-445.08K | 51.21%-817.92K |
| Cash dividends paid | -288.36%-2.1M | -15.84%-539.58K | 3.55%-465.81K | 5.14%-482.93K | 8.90%-509.1K | 7.63%-558.81K | 29.05%-605K | 22.02%-852.69K | 2.94%-1.09M | 5.49%-1.13M |
| Net other financing activities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 489.93%41.61M | 800.86%7.05M | -53.26%-1.01M | 58.80%-656.59K | 3.66%-1.59M | -8.85%-1.65M | 88.20%-1.52M | -650.45%-12.88M | 18.37%-1.72M | 41.72%-2.1M |
| Net cash flow | ||||||||||
| Beginning cash position | -80.02%89.7K | 156.80%449.06K | -17.99%174.87K | 93.54%213.22K | -81.56%110.17K | -84.43%597.27K | 269.02%3.83M | -15.29%1.04M | 6.15%1.23M | 173.58%1.16M |
| Current changes in cash | 1,163.62%3.82M | -231.06%-359.36K | 814.96%274.19K | -137.22%-38.35K | 121.16%103.05K | 84.95%-487.11K | -215.81%-3.24M | 1,590.91%2.8M | -363.90%-187.52K | -90.31%71.06K |
| End cash position | 4,261.00%3.91M | -80.02%89.7K | 156.80%449.06K | -17.99%174.87K | 93.54%213.22K | -81.56%110.17K | -84.43%597.27K | 269.02%3.83M | -15.29%1.04M | 6.15%1.23M |
| Free cash from | -409.76%-37.78M | -678.85%-7.41M | 107.12%1.28M | -63.56%618.24K | 45.38%1.7M | 167.93%1.17M | -110.96%-1.72M | 925.46%15.67M | -29.67%1.53M | -49.93%2.17M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.